Brief: Eli Lilly declines to comment on market talk about Abivax interest
10/12/2025 13:00
Eli Lilly LLY.N: SAYS ON ABIVAX INTEREST SPECULATION: 'WE DO NOT COMMENT ON BUSINESS DEVELOPMENT ACTIVITY' Source text: ID:nL8N3XG0O3 Further company coverage: LLY.N (Reporting by Danilo Masoni; Editing by Amanda Cooper) ((Danilo.Masoni@tr.com;))
Recent news on Abivax SA
See all newsAbivax shares fall after rival drug data, trader says
France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data